Decitabine in Treating Patients With Myelodysplastic Syndrome - Contacts and Locations

Decitabine in Treating Patients With Myelodysplastic Syndrome

This study is ongoing, but not recruiting participants.

Study NCT00003361. Last updated on July 23, 2008. Information provided by National Cancer Institute (NCI)

Please refer to this study by its ClinicalTrials.gov identifier: NCT00003361

Locations


United States, Maryland
	Johns Hopkins Oncology Center
	Baltimore, Maryland, United States, 21231-2410

United States, New York
	Memorial Sloan-Kettering Cancer Center
	New York, New York, United States, 10021

United States, Texas
	University of Texas - MD Anderson Cancer Center
	Houston, Texas, United States, 77030-4009

Sponsors and Collaborators

Memorial Sloan-Kettering Cancer Center

National Cancer Institute (NCI)

Investigators


Study Chair:	Stephen D. Nimer, MD	Memorial Sloan-Kettering Cancer Center